The diabetic population of the world is steadily rising and giving birth to a new economy that is completely based on a plethora of treatments related to diabetes. According to a report published by National Diabetes Federation the diabetic population around the world will rise to 642 million by 2020. Presently almost 672 billion US dollars is what the world spends on treating diabetic patients. According to WHO, the young adults are the worst affected segment of the population. According to a market insight published by Future Market Insights (FMI) the demand for the diabetic treatment tools will surge in the coming few years. To meet up this market demand, leading company Becton, Dickinson and Company operating in the GCC syringes and needles market has recently launched a syringe designed for the use of Humulin. The medical fraternity believes that this revolutionary tool will iron out the limitations of diabetic treatment.
Humulin R U- 500 insulin widely used by the population with high blood sugar. These lot of diabetic patients need a large dose of insulin to keep diabetes in control. The bodies of these patients are unable to process to proper normal doses of insulin. Presently the global intake of insulin amongst the diabetic population is soaring with time. Not only adults even the worst affected young population is also surviving under the heavy doses of insulin. Presently 3.7 percent of diabetes affected population of US needs approximately 200 units of insulin per day which opens a massive window for this new product launched by Becton, Dickinson and Company. This new syringe will be extremely useful for people with high diabetes levels. The U-500 insulin syringe is able to inject a proper dosage of insulin into the patient’s body. Becton, Dickinson and Company has collaborated with Lilly Diabetes to curate this product. The BD U-500 insulin syringe is the smallest needle available in the market. Find out more by accessing free sample of the report on the GCC syringes and needles market at
Find out more by accessing free sample of the report on the GCC syringes and needles market at http://www.futuremarketinsights.com/reports/sample/rep-gc-1874
